Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study is now listed as completed and no longer recruiting, replacing its prior not-yet-recruiting/unknown status. The latest record version also includes changes to study status, recruitment status, study design, and contacts/locations.
    Difference
    2%
    Check dated 2026-11-10T06:43:05.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision shown in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T02:14:00.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner was added announcing changes to NIH websites and explaining that some NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    0.9%
    Check dated 2026-10-27T02:21:13.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-20T05:00:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-13T07:49:46.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 appears in the Study Record Versions, indicating the latest update to the record history. This reflects administrative versioning rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-22T02:27:55.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.